ATE405250T1 - Teilchen mit maskiertem gefüge, einen wirkstoff enthaltend - Google Patents

Teilchen mit maskiertem gefüge, einen wirkstoff enthaltend

Info

Publication number
ATE405250T1
ATE405250T1 AT01310751T AT01310751T ATE405250T1 AT E405250 T1 ATE405250 T1 AT E405250T1 AT 01310751 T AT01310751 T AT 01310751T AT 01310751 T AT01310751 T AT 01310751T AT E405250 T1 ATE405250 T1 AT E405250T1
Authority
AT
Austria
Prior art keywords
particles
active substance
masked structure
masked
substance
Prior art date
Application number
AT01310751T
Other languages
English (en)
Inventor
Narendra Parikh
Daniel Mcteigue
David W Wynn
Ravivaj S Pillai
Original Assignee
Mcneil Ppc Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneil Ppc Inc filed Critical Mcneil Ppc Inc
Application granted granted Critical
Publication of ATE405250T1 publication Critical patent/ATE405250T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01310751T 2000-12-21 2001-12-21 Teilchen mit maskiertem gefüge, einen wirkstoff enthaltend ATE405250T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/745,243 US20020119196A1 (en) 2000-12-21 2000-12-21 Texture masked particles containing an active ingredient

Publications (1)

Publication Number Publication Date
ATE405250T1 true ATE405250T1 (de) 2008-09-15

Family

ID=24995856

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01310751T ATE405250T1 (de) 2000-12-21 2001-12-21 Teilchen mit maskiertem gefüge, einen wirkstoff enthaltend

Country Status (17)

Country Link
US (2) US20020119196A1 (de)
EP (1) EP1219291B1 (de)
JP (1) JP2002272817A (de)
KR (1) KR20020050754A (de)
CN (1) CN100544705C (de)
AR (1) AR032037A1 (de)
AT (1) ATE405250T1 (de)
AU (1) AU783593B2 (de)
BR (1) BR0106912A (de)
CA (1) CA2365844C (de)
CO (1) CO5390070A1 (de)
DE (1) DE60135435D1 (de)
ES (1) ES2311007T3 (de)
HK (2) HK1045817B (de)
MX (1) MXPA02000277A (de)
NZ (1) NZ516341A (de)
ZA (1) ZA200110547B (de)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
GB2384986B (en) * 2002-02-12 2004-01-07 Reckitt Benckiser Healthcare Compositions for the treatment of disorders of the upper gastrointestinal tract
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals
US6941948B2 (en) 2002-03-07 2005-09-13 Vectura Drug Delivery Medicament storage and delivery devices
US20040001885A1 (en) * 2002-06-27 2004-01-01 Unchalee Kositprapa Rapidly disintegrating antihistamine formulation
US7384970B2 (en) * 2003-03-24 2008-06-10 Irm Llc Inhibitors of cathepsin S
US20050042289A1 (en) * 2003-04-29 2005-02-24 Yamanouchi Pharma Technologies, Inc. Tablets and methods for modified release of hydrophylic and other active agents
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US20050053655A1 (en) * 2003-09-05 2005-03-10 Pharmaceutical Industry Technology And Development Center Rapid disintegrating tablets (RDTs) for pharmaceutical use and method for preparing the same
CA2543454A1 (en) * 2003-10-27 2005-05-06 Astellas Pharma Inc. Drug-containing coated microparticles for quick-disintegrating oral tablets
US20050175689A1 (en) * 2003-10-27 2005-08-11 Yamanouchi Pharmaceutical Co., Ltd. Coated fine particles containing drug for intrabuccally fast disintegrating tablet
US7201920B2 (en) 2003-11-26 2007-04-10 Acura Pharmaceuticals, Inc. Methods and compositions for deterring abuse of opioid containing dosage forms
US7879354B2 (en) * 2004-01-13 2011-02-01 Mcneil-Ppc, Inc. Rapidly disintegrating gelatinous coated tablets
US8039482B2 (en) * 2004-03-25 2011-10-18 Astellas Pharma Inc. Composition of solifenacin or salt thereof for use in solid formulation
WO2006070735A1 (ja) * 2004-12-27 2006-07-06 Astellas Pharma Inc. ソリフェナシンまたはその塩の安定な粒子状医薬組成物
US20060198885A1 (en) * 2005-02-22 2006-09-07 Sun Pharmaceutical Industries Ltd. Oral pharmaceutical composition
US7815939B2 (en) * 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
EP1911444A1 (de) * 2005-07-20 2008-04-16 Astellas Pharma Inc. Arzneimittelhaltiges beschichtetes feinesteilchen für eine intrabukkal zerfallende zubereitung undherstellungsverfahren dafür
US20070077300A1 (en) 2005-09-30 2007-04-05 Wynn David W Oral compositions containing a salivation inducing agent
PL2379056T3 (pl) * 2008-11-28 2016-10-31 Stała kompozycja farmaceutyczna zawierająca co najmniej jeden środek stabilizujący
WO2010078541A1 (en) * 2009-01-05 2010-07-08 Mcneil-Ppc, Inc. Tablet containing coated particles of cetirizine, pseudoephedrine, and/or naproxen
US8246988B2 (en) * 2009-01-05 2012-08-21 Mcneil-Ppc, Inc. Three layer tablet containing cetirizine, pseudoephedrine, and naproxen
US8377475B2 (en) * 2009-01-05 2013-02-19 Mcneil-Ppc, Inc. Tablet containing cetirizine, pseudoephedrine, and naproxen containing a barrier layer
EP3064064A1 (de) * 2009-09-30 2016-09-07 Acura Pharmaceuticals, Inc. Verfahren und zusammensetzungen zur abschreckung vor missbrauch
SG10201407965XA (en) * 2009-12-02 2015-02-27 Aptalis Pharma Ltd Fexofenadine microcapsules and compositions containing them
EP2515836B1 (de) 2009-12-23 2014-06-04 Colgate-Palmolive Company Visuell strukturierte und ausgerichtete zusammensetzungen
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
WO2012061360A2 (en) 2010-11-01 2012-05-10 Rib-X Pharmaceuticals, Inc. Pharmaceutical compositions
WO2012170883A1 (en) * 2011-06-09 2012-12-13 Discovery Pharma Consulting, Llc Antihistamines combined with dietary supplements for improved health
EP2802311B1 (de) 2011-10-25 2018-12-12 Expermed S.A. Sublinguale pharmazeutische zusammensetzung mit einem antimuskarinischen wirkstoff und herstellungsverfahren dafür
US20130177646A1 (en) * 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
CN104968333B (zh) 2012-11-30 2018-07-10 阿库拉制药公司 活性药物成分的自调节释放
DK3003285T3 (en) * 2013-06-03 2022-04-04 Mcneil Ab Fast farmaceutisk dosisform til frigivelse af mindst to aktive farmaceutiske ingredienser i mundhulen
ES2683154T3 (es) * 2013-12-04 2018-09-25 Hovione Scientia Limited Medios de contraste que contienen formulaciones de enmascaramiento del sabor
ES2856347T3 (es) * 2014-02-12 2021-09-27 Sawai Seiyaku Kk Comprimido desintegrante oralmente recubierto con película
JP6510628B2 (ja) 2014-03-26 2019-05-15 サン・ファーマ・アドバンスト・リサーチ・カンパニー・リミテッド 乱用防止即時放出性被覆リザーバ固体剤形
WO2017040607A1 (en) 2015-08-31 2017-03-09 Acura Pharmaceuticals, Inc. Methods and compositions for self-regulated release of active pharmaceutical ingredient
WO2017151571A1 (en) * 2016-02-29 2017-09-08 First Time Us Generics Llc Abuse deterrent soft chewable drug formulations
CN122182527A (zh) 2016-05-05 2026-06-12 阿奎斯蒂弗医疗股份有限公司 增强递送的肾上腺素组合物
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
CN109562075A (zh) * 2016-07-05 2019-04-02 葛兰素史克消费保健(美国)控股有限责任公司 包含快速释放外包衣的口服剂型
IL262768B (en) * 2018-11-04 2020-08-31 Ambrosia Supherb Ltd A chewable tablet and method of preparing the same
WO2023076281A1 (en) 2021-10-25 2023-05-04 Aquestive Therapeutics, Inc. Oral and nasal compositions and methods of treatment
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3431138A (en) * 1967-07-14 1969-03-04 American Cyanamid Co Method for coating pharmaceutical forms with methyl cellulose
JPS5535031A (en) * 1978-09-04 1980-03-11 Shin Etsu Chem Co Ltd Enteric coating composition
US4309405A (en) * 1979-08-09 1982-01-05 American Home Products Corporation Sustained release pharmaceutical compositions
US4749575A (en) * 1983-10-03 1988-06-07 Bio-Dar Ltd. Microencapsulated medicament in sweet matrix
JPS61174940A (ja) * 1985-01-29 1986-08-06 Oogawara Kakoki Kk ワックス類コーテイング単核状マイクロカプセルおよびその製造方法
US4868183A (en) * 1986-07-21 1989-09-19 Otsuka Pharmaceutical Factory, Inc. N-pyrazinyl substituted P-aminophenols
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
DK130287D0 (da) * 1987-03-13 1987-03-13 Benzon As Alfred Oralt praeparat
US4916161A (en) * 1988-10-25 1990-04-10 Bristol-Myers Squibb Taste-masking pharmaceutical agents
US5372823A (en) * 1989-03-16 1994-12-13 Bristol-Myers Squibb Company Direct compression cholestyramine tablet and solvent-free coating thereof
DE69128682T2 (de) * 1990-03-28 1998-06-04 Otsuka Pharma Co Ltd Chinolinderivat, antiulcus-mittel das dieses derivat enthält und darstellung dieses derivates
IT1246383B (it) * 1990-04-17 1994-11-18 Eurand Int Metodo per il mascheramento del sapore di farmaci
US5075114A (en) * 1990-05-23 1991-12-24 Mcneil-Ppc, Inc. Taste masking and sustained release coatings for pharmaceuticals
EP0458751A1 (de) * 1990-05-25 1991-11-27 Warner-Lambert Company System zur Freisetzung von cyclischen Aminosäuren mit verbessertem Geschmack, Struktur und Komprimierbarkeit
GB9114184D0 (en) * 1991-07-01 1991-08-21 Unilever Plc Detergent composition
US5837277A (en) * 1992-06-04 1998-11-17 Smithkline Beecham Corporation Palatable pharmaceutical compositions
IT1264020B (it) * 1993-01-28 1996-09-09 Recordati Chem Pharm Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi
PT621032E (pt) * 1993-04-23 2001-01-31 Novartis Ag Dispositivo de distribuicao de libertacao controlada de farmaco
EP0711166A1 (de) * 1993-07-22 1996-05-15 Warner-Lambert Company Tacrin-arzneistoffabgabesysteme mit kontrollierter freisetzung und herstellungsverfahren
ZA945944B (en) * 1993-08-13 1996-02-08 Eurand America Inc Procedure for encapsulating nsaids
JPH07223970A (ja) * 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd 消化管内適所放出製剤
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
US5536507A (en) * 1994-06-24 1996-07-16 Bristol-Myers Squibb Company Colonic drug delivery system
US5681382A (en) * 1995-08-22 1997-10-28 Shin-Etsu Chemical Co., Ltd. Rapidly soluble coating composition and method for preparing same
US5789014A (en) * 1995-12-25 1998-08-04 Shin-Etsu Chemical Co., Ltd. Method of manufacturing a solid preparation coated with non-solvent coating
SE507471C2 (sv) * 1996-08-09 1998-06-08 Sunds Defibrator Ind Ab Silpanel samt sätt för dess framställning
WO1998014179A1 (en) * 1996-10-01 1998-04-09 Cima Labs Inc. Taste-masked microcapsule compositions and methods of manufacture
US6046177A (en) * 1997-05-05 2000-04-04 Cydex, Inc. Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
US6090401A (en) * 1999-03-31 2000-07-18 Mcneil-Ppc, Inc. Stable foam composition
US7223421B2 (en) * 2000-06-30 2007-05-29 Mcneil-Ppc, Inc. Teste masked pharmaceutical particles

Also Published As

Publication number Publication date
CO5390070A1 (es) 2004-04-30
HK1045817B (en) 2009-06-05
KR20020050754A (ko) 2002-06-27
ES2311007T3 (es) 2009-02-01
AR032037A1 (es) 2003-10-22
BR0106912A (pt) 2003-09-16
US20020119196A1 (en) 2002-08-29
CN1366878A (zh) 2002-09-04
MXPA02000277A (es) 2004-05-21
EP1219291A1 (de) 2002-07-03
JP2002272817A (ja) 2002-09-24
CA2365844A1 (en) 2002-06-21
AU783593B2 (en) 2005-11-10
CN100544705C (zh) 2009-09-30
EP1219291B1 (de) 2008-08-20
ZA200110547B (en) 2003-07-30
NZ516341A (en) 2003-08-29
US20120251623A1 (en) 2012-10-04
HK1045817A1 (en) 2002-12-13
DE60135435D1 (de) 2008-10-02
AU9736101A (en) 2002-06-27
CA2365844C (en) 2010-07-06
HK1046865A1 (zh) 2003-01-30

Similar Documents

Publication Publication Date Title
DE60135435D1 (de) Teilchen mit maskiertem Gefüge, einen Wirkstoff enthaltend
DE69928085D1 (de) Dosierungsform mit verlängerter wirkstoffabgabe
NO20024170L (no) Forminsket, nållös injektor
ATE404180T1 (de) Geschmacksmaskierte pharmazeutische partikel
BR0100865B8 (pt) artigo absorvente.
BR0103836B1 (pt) artigo absorvente.
BR0100151B1 (pt) artigo absorvente.
MXPA03001148A (es) Antibioticos macrolidos.
BR0208970B1 (pt) produto absorvente com ajuste melhorado.
BR0208971B1 (pt) produto absorvente com ajuste melhorado.
BR0102028B1 (pt) artigo absorvente.
DE60135956D1 (de) Zerstäubungsvorrichtung
DE69919490D1 (de) Puder mit fettlöslichem wirkstoff
DE50014678D1 (de) Aktive Filterschaltung mit Operationsverstärker
DE60012363D1 (de) Elektrode mit katalytischem pulver hergestellt
DE60101749D1 (de) Münzenvereinzelungsgerät
ATE412405T1 (de) Pharmazeutische zusammensetzung mit modifiziertem träger
DE60129123D1 (de) BIOLOGISCH AKTIVE 4H-BENZOi1,4öOXAZIN-3-ONE
BR0107047B1 (pt) artigo absorvente.
AU7384401A (en) Active substance conjugates with intracellularly active ligands
DE50102863D1 (de) Bauelement mit akustisch aktivem material
DE50114704D1 (de) Dosierbunker
DE60122623D1 (de) Beschichtetes Material umfassend einen porösen Träger
NL1016133A1 (nl) Accukruik.
ES1043699Y (es) Dispositivo nebulizador.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties